29 results on '"Pasoglou V"'
Search Results
2. MRI detection of radiographically occult fractures of the hip and pelvis in the elderly: Comparison of T2-weighted Dixon sequence with T1-weighted and STIR sequences
- Author
-
Heynen, B., Tamigneaux, C., Pasoglou, V., Malghem, J., Vande Berg, B., and Kirchgesner, T.
- Published
- 2019
- Full Text
- View/download PDF
3. MRI for response assessment in metastatic bone disease
- Author
-
Lecouvet, F. E., Larbi, A., Pasoglou, V., Omoumi, P., Tombal, B., Michoux, N., Malghem, J., Lhommel, R., and Vande Berg, B. C.
- Published
- 2013
- Full Text
- View/download PDF
4. Detection and Characterization of Musculoskeletal Cancer Using Whole-Body Magnetic Resonance Imaging
- Author
-
Isaac, A. Lecouvet, F. Dalili, D. Fayad, L. Pasoglou, V. Papakonstantinou, O. Ahlawat, S. Messiou, C. Weber, M.-A. Padhani, A.R.
- Abstract
Whole-body magnetic resonance imaging (WB-MRI) is gradually being integrated into clinical pathways for the detection, characterization, and staging of malignant tumors including those arising in the musculoskeletal (MSK) system. Although further developments and research are needed, it is now recognized that WB-MRI enables reliable, sensitive, and specific detection and quantification of disease burden, with clinical applications for a variety of disease types and a particular application for skeletal involvement. Advances in imaging techniques now allow the reliable incorporation of WB-MRI into clinical pathways, and guidelines recommending its use are emerging. This review assesses the benefits, clinical applications, limitations, and future capabilities of WB-MRI in the context of other next-generation imaging modalities, as a qualitative and quantitative tool for the detection and characterization of skeletal and soft tissue MSK malignancies. © 2020 BMJ Publishing Group. All rights reserved.
- Published
- 2020
5. Familial Adhesive Arachnoiditis Associated with Syringomyelia
- Author
-
Pasoglou, V., primary, Janin, N., additional, Tebache, M., additional, Tegos, T. J., additional, Born, J. D., additional, and Collignon, L., additional
- Published
- 2014
- Full Text
- View/download PDF
6. P101 One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all-in-one” imaging approach?
- Author
-
Pasoglou, V., primary, Larbi, A., additional, Collette, L., additional, Annet, L., additional, Jamar, F., additional, Machiels, J.-P., additional, Michoux, N., additional, Lecouvet, F., additional, and Tombal, B., additional
- Published
- 2013
- Full Text
- View/download PDF
7. Imaging of traumatic and atraumatic penile lumps
- Author
-
Frédéric Lecouvet, Marin Halut, Hélène Dano, Axel Feyaerts, Vassiliki Pasoglou, Camilla Sachs, Michele Bertolotto, Etienne Danse, Julien Van Damme, Sandy Van Nieuwenhove, Van Nieuwenhove, S., Van Damme, J., Feyaerts, A., Sachs, C., Halut, M., Pasoglou, V., Lecouvet, F., Danse, E., Dano, H., Bertolotto, M., UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale, UCL - (SLuc) Service de radiologie, UCL - (SLuc) Service d'urologie, UCL - (SLuc) Centre de pathologie sexuelle masculine, UCL - (SLuc) Centre du cancer, and UCL - (SLuc) Service d'anatomie pathologique
- Subjects
Diagnostic Imaging ,Male ,medicine.medical_specialty ,Penis lump ,Shoulder Joint ,Vascular disease ,business.industry ,MEDLINE ,Penis lumps ,imaging ,medicine.disease ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,surgical procedures, operative ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Radiology ,skin and connective tissue diseases ,business ,Penis - Abstract
Palpable nodules on the penile shaft, called penile lumps, are encountered in benign conditions such as Peyronie disease and in malignant lesions such as squamous cell carcinoma. Malignant lesions of the penis account for less than 1% of all malignant cancers in the United States, and of these, approximately 95% are squamous cell carcinomas. The diagnostic approach is primarily clinical and depends on the patient’s medical history and the onset of the symptoms. Imaging examinations, including principally US and MRI, play a role in staging, preoperative planning, and assessing the vasculature and viability of the penile tissues. Because of the relative infrequency of penile diseases, performing and interpreting penile imaging studies can be challenging for radiologists with less experience in urogenital imaging.
- Published
- 2021
8. Value of Whole-body Magnetic Resonance Imaging Using the MET-RADS-P Criteria for Assessing the Response to Intensified Androgen Deprivation Therapy in Metastatic Hormone-naïve and Castration-resistant Prostate Cancer.
- Author
-
Van Damme J, Tombal B, Michoux N, Van Nieuwenhove S, Pasoglou V, Triqueneaux P, Padhani AR, and Lecouvet FE
- Abstract
Background and Objectives: We assessed the agreement between prostate-specific antigen (PSA) and imaging responses using whole-body magnetic resonance imaging (wbMRI). Our aim was to explore the potential prognostic value of PSA and wbMRI responses in metastatic hormone-naïve prostate cancer (mHNPC) and castration-resistant PC (mCRPC)., Methods: wbMRI was prospectively performed in 37 patients with mHNPC and 51 with mCRPC before and after 6-12 mo of androgen deprivation therapy and an androgen receptor pathway inhibitor (ARPI). Imaging responses were defined according to the Metastasis Reporting and Data System for PC (MET-RADS-P) criteria. A PSA response was defined as PSA ≤0.2 ng/ml in mHNPC and a ≥50% decrease from the pretreatment level in mCRPC. Agreement between PSA and wbMRI responses was assessed using Cohen's κ. The association between time to subsequent treatment and overall survival (OS) was analyzed using Cox regression analysis., Key Findings and Limitations: Agreement between PSA and wbMRI responses was fair in mHNPC (κ = 0.30) but none to slight in mCRPC (κ = 0.15). In mHNPC, patients with a PSA or wbMRI response were less likely to receive subsequent treatments; wbMRI progression was associated with a significantly higher risk of death (hazard ratio 8.59; p = 0.002). In mCRPC, two-thirds of patients with a PSA response showed progression on wbMRI; neither PSA nor wbMRI progression changed the likelihood of starting a subsequent treatment or the risk of death., Conclusions and Clinical Implications: In mHNPC, wbMRI progression was associated with a higher risk of needing subsequent treatment and shorter OS., Patient Summary: We evaluated the agreement between routine PSA (prostate-specific antigen) test results and whole-body MRI (magnetic resonance imaging) scans for assessing the response of metastatic prostate cancer to treatment. There was disagreement between the PSA and MRI results, mainly for patients with cancer that was resistant to hormone-based treatment. Combining PSA with whole-body MRI might provide a more accurate picture of the response of advanced prostate cancer to treatment., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. CT of the urinary tract revisited.
- Author
-
Tsili AC, Varkarakis I, Pasoglou V, Anagnostou N, and Argyropoulou MI
- Subjects
- Humans, Hematuria diagnostic imaging, Hematuria etiology, Tomography, X-Ray Computed methods, Urography methods, Urinary Tract diagnostic imaging, Urinary Bladder Neoplasms, Urologic Neoplasms diagnostic imaging, Carcinoma, Transitional Cell, Urologic Diseases diagnostic imaging, Kidney Neoplasms diagnostic imaging
- Abstract
Computed tomography (CT) of the abdomen is usually appropriate for the initial imaging of many urinary tract diseases, due to its wide availability, fast scanning and acquisition of thin slices and isotropic data, that allow the creation of multiplanar reformatted and three-dimensional reconstructed images of excellent anatomic details. Non-enhanced CT remains the standard imaging modality for assessing renal colic. The technique allows the detection of nearly all types of urinary calculi and the estimation of stone burden. CT is the primary diagnostic tool for the characterization of an indeterminate renal mass, including both cystic and solid tumors. It is also the modality of choice for staging a primary renal tumor. Urolithiasis and urinary tract malignancies represent the main urogenic causes of hematuria. CT urography (CTU) improves the visualization of both the upper and lower urinary tract and is recommended for the investigation of gross hematuria and microscopic hematuria, in patients with predisposing factors for urologic malignancies. CTU is highly accurate in the detection and staging of upper tract urothelial malignancies. CT represents the most commonly used technique for the detection and staging of bladder carcinoma and the diagnostic efficacy of CT staging improves with more advanced disease. Nevertheless, it has limited accuracy in differentiating non-muscle invasive bladder carcinoma from muscle-invasive bladder carcinoma. In this review, clinical indications and the optimal imaging technique for CT of the urinary tract is reviewed. The CT features of common urologic diseases, including ureterolithiasis, renal tumors and urothelial carcinomas are discussed., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
10. Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions.
- Author
-
Van Nieuwenhove S, Van Damme J, Padhani AR, Vandecaveye V, Tombal B, Wuts J, Pasoglou V, and Lecouvet FE
- Subjects
- Humans, Magnetic Resonance Imaging methods, Male, Neoplasm Staging, Positron Emission Tomography Computed Tomography methods, Tomography, X-Ray Computed, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology, Whole Body Imaging methods
- Abstract
Over the past decade, updated definitions for the different stages of prostate cancer and risk for distant disease, along with the advent of new therapies, have remarkably changed the management of patients. The two expectations from imaging are accurate staging and appropriate assessment of disease response to therapies. Modern, next-generation imaging (NGI) modalities, including whole-body magnetic resonance imaging (WB-MRI) and nuclear medicine (most often prostate-specific membrane antigen [PSMA] positron emission tomography [PET]/computed tomography [CT]) bring added value to these imaging tasks. WB-MRI has proven its superiority over bone scintigraphy (BS) and CT for the detection of distant metastasis, also providing reliable evaluations of disease response to treatment. Comparison of the effectiveness of WB-MRI and molecular nuclear imaging techniques with regard to indications and the definition of their respective/complementary roles in clinical practice is ongoing. This paper illustrates the evolution of WB-MRI imaging protocols, defines the current state-of-the art, and highlights the latest developments and future challenges. The paper presents and discusses WB-MRI indications in the care pathway of men with prostate cancer in specific key situations: response assessment of metastatic disease, "all in one" cancer staging, and oligometastatic disease., (© 2020 International Society for Magnetic Resonance in Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
11. Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell Cancer.
- Author
-
Pasoglou V, Van Nieuwenhove S, Van Damme J, Michoux N, Van Maanen A, Annet L, Machiels JP, Tombal B, and Lecouvet FE
- Abstract
Whole-Body Magnetic Resonance Imaging (WB-MRI) is increasingly used for metastatic screening in oncology. This prospective single center study assesses the diagnostic value of WB-MRI including diffusion weighted imaging (DWI) and identifies the sufficient protocol for metastatic lymph node detection in patients with testicular germ cell cancer (TGCC). Forty-three patients underwent contrast enhanced thoraco-abdominopelvic CT (TAP-CT) and WB-MRI with DWI for metastatic lymph node screening. Two independent readers reviewed CTs and WB-MRIs. The diagnostic performance of different imaging protocols (CT, complete WB-MRI, T1W + DWI, T2W + DWI), the agreement between these protocols and the reference standard, the reproducibility of findings and the image quality (Signal and contrast to Noise Ratios, Likert scale) were studied. Reproducibility was very good regardless of both lesion locations (retroperitoneal vs distant lymph nodes, other lesions) and the reader. Diagnostic accuracy of MRI was ≥95% (regardless of the locations and imaging protocol); accuracy of CT was ≥93%. There was a strict overlap of 95% CIs associated with this accuracy between complete WB-MRI, T1W + DWI and T2W + DWI, regardless of the reader. Higher Likert score and SNR were observed for DWI, followed by T2W and T1W sequences. In conclusion, a fast WB-MRI protocol including T2W and DWI is a sufficient, accurate, non-irradiating alternative to TAP-CT for metastatic lymph node screening in TGCC.
- Published
- 2022
- Full Text
- View/download PDF
12. Comparison of 68 Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer.
- Author
-
Van Damme J, Tombal B, Collette L, Van Nieuwenhove S, Pasoglou V, Gérard T, Jamar F, Lhommel R, and Lecouvet FE
- Abstract
Background: Prostate specific membrane antigen (PSMA) positron emission tomography computed tomography (PET-CT) and whole-body magnetic resonance imaging (WB-MRI) outperform standard imaging technology for the detection of metastasis in prostate cancer (PCa). There are few direct comparisons between both modalities. This paper compares the diagnostic accuracy of PSMA PET-CT and WB-MRI for the detection of metastasis in PCa. One hundred thirty-four patients with newly diagnosed PCa ( n = 81) or biochemical recurrence after curative treatment ( n = 53) with high-risk features prospectively underwent PSMA PET-CT and WB-MRI. The diagnostic accuracy of both techniques for lymph node, skeletal and visceral metastases was compared against a best valuable comparator (BVC). Overall, no significant difference was detected between PSMA PET-CT and WB-MRI to identify metastatic patients when considering lymph nodes, skeletal and visceral metastases together (AUC = 0.96 (0.92-0.99) vs. 0.90 (0.85-0.95); p = 0.09). PSMA PET-CT, however, outperformed WB-MRI in the subgroup of patients with newly diagnosed PCa for the detection of lymph node metastases (AUC = 0.96 (0.92-0.99) vs. 0.86 (0.79-0.92); p = 0.0096). In conclusion, PSMA PET-CT outperforms WB-MRI for the detection of nodal metastases in primary staging of PCa.
- Published
- 2021
- Full Text
- View/download PDF
13. 3D Whole-Body MRI of the Musculoskeletal System.
- Author
-
Pasoglou V, Van Nieuwenhove S, Peeters F, Duchêne G, Kirchgesner T, and Lecouvet FE
- Subjects
- Humans, Imaging, Three-Dimensional, Magnetic Resonance Imaging, Musculoskeletal System diagnostic imaging, Whole Body Imaging
- Abstract
With its outstanding soft tissue contrast, spatial resolution, and multiplanar capacities, magnetic resonance imaging (MRI) has become a widely used technique. Whole-body MRI (WB-MRI) has been introduced among diagnostic methods for the staging and follow-up assessment in oncologic patients, and international guidelines recommend its use. In nononcologic applications, WB-MRI is as a promising imaging tool in inflammatory diseases, such as seronegative arthritis and inflammatory myopathies. Technological advances have facilitated the introduction of three-dimensional (3D) almost isotropic sequences in MRI examinations covering the whole body. The possibility to reformat 3D images in any plane with equal or almost equal resolution offers comprehensive understanding of the anatomy, easier disease detection and characterization, and finally contributes to correct treatment planning. This article illustrates the basic principles, advantages, and limitations of the 3D approach in WB-MRI examinations and provides a short review of the literature., Competing Interests: None declared., (Thieme. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
14. Imaging of Traumatic and Atraumatic Penile Lumps.
- Author
-
Van Nieuwenhove S, Van Damme J, Feyaerts A, Sachs C, Halut M, Pasoglou V, Lecouvet F, Danse E, Dano H, and Bertolotto M
- Subjects
- Diagnostic Imaging, Humans, Male, Penis diagnostic imaging, Shoulder Joint
- Published
- 2021
- Full Text
- View/download PDF
15. Detection and Characterization of Musculoskeletal Cancer Using Whole-Body Magnetic Resonance Imaging.
- Author
-
Isaac A, Lecouvet F, Dalili D, Fayad L, Pasoglou V, Papakonstantinou O, Ahlawat S, Messiou C, Weber MA, and Padhani AR
- Subjects
- Bone Neoplasms pathology, Humans, Muscle Neoplasms pathology, Soft Tissue Neoplasms pathology, Bone Neoplasms diagnostic imaging, Magnetic Resonance Imaging methods, Muscle Neoplasms diagnostic imaging, Soft Tissue Neoplasms diagnostic imaging, Whole Body Imaging methods
- Abstract
Whole-body magnetic resonance imaging (WB-MRI) is gradually being integrated into clinical pathways for the detection, characterization, and staging of malignant tumors including those arising in the musculoskeletal (MSK) system. Although further developments and research are needed, it is now recognized that WB-MRI enables reliable, sensitive, and specific detection and quantification of disease burden, with clinical applications for a variety of disease types and a particular application for skeletal involvement. Advances in imaging techniques now allow the reliable incorporation of WB-MRI into clinical pathways, and guidelines recommending its use are emerging. This review assesses the benefits, clinical applications, limitations, and future capabilities of WB-MRI in the context of other next-generation imaging modalities, as a qualitative and quantitative tool for the detection and characterization of skeletal and soft tissue MSK malignancies., Competing Interests: None declared., (Thieme. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
16. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.
- Author
-
Lecouvet FE, Pasoglou V, Van Nieuwenhove S, Van Haver T, de Broqueville Q, Denolin V, Triqueneaux P, Tombal B, and Michoux N
- Subjects
- Aged, Aged, 80 and over, Humans, Lymphatic Metastasis, Male, Middle Aged, Prostatic Neoplasms secondary, Reproducibility of Results, Diffusion Magnetic Resonance Imaging methods, Early Detection of Cancer methods, Prostatic Neoplasms diagnosis, Whole Body Imaging methods
- Abstract
Purpose: To compare 3D T1-weighted fast spin echo (FSE) and 3D T1-weighted gradient echo (GE) mDixon as morphologic sequences to complement diffusion-weighted imaging (DWI) for the metastatic screening in prostate cancer (PCa) patients., Materials and Methods: Thirty PCa patients at high risk of metastases prospectively underwent both a 3D T1 FSE (14 min) and a rapid 3D T1 GE
mDixon (1 min 20 s) sequences within a WB-MRI protocol. Two readers assessed the diagnostic performance of the FSE/Fat/in-phase (IP)/IP+Fat sequences in detecting bone and node metastases. The reference standard was established by a panel of four physicians on the basis of all baseline and follow-up imaging, biological and clinical information. The reproducibility of readings, predictive accuracy (Acc) from ROC curves analysis, and contrast-to-reference ratio (CRR) in lesions were assessed for each sequence., Results: In bone and lymph nodes (per-region analysis), reproducibility was at least good for all sequences/readers, except for nodes in the common iliac/inguinal regions. In bone (per-organ analysis), Acc of FSE was superior to that of mDixon (difference + 4%, p < 0.0083). In nodes (per-organ analysis), Acc of Fat was superior to that of other sequences (difference + 4% to + 6% depending on reader, p < 0.0083). In the per-patient analysis, Acc of FSE was superior to that of mDixon (difference + 4% to + 6% depending on sequence, p < 0.0083). Fat images had higher CRR compared with FSE in the thoracic spine, the bony pelvis and lymph node metastases (p < 0.025)., Conclusion: 3D T1 GEmDixon may replace 3D T1 FSE to complement DWI in WB-MRI for metastatic screening in PCa. It demonstrates an Acc ranging from + 4% to + 6% (nodes) to - 4% to - 6% (bone and patient staging) compared with FSE and considerably reduces the examination time, offering the perspective of acquiring WB-MRI examinations in less than 20 min., Key Points: • The replacement of 3D T1 FSE by the 3D T1 GE mDixon as morphologic sequence to complement DWI drastically reduces the acquisition time of WB-MRI studies. • The 3D T1 GE mDixon sequence offers similar reproducibility of image readings compared with that of the 3D T1 FSE. • Differences in diagnostic accuracy are limited (+ 4%/+ 6% in favor of mDixon to detect node metastases; + 4%/+ 6% in favor of FSE to detect bone metastases/metastatic disease in a patient).- Published
- 2020
- Full Text
- View/download PDF
17. MRI versus 18 F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance.
- Author
-
Lecouvet FE, Boyadzhiev D, Collette L, Berckmans M, Michoux N, Triqueneaux P, Pasoglou V, Jamar F, and Vekemans MC
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Radiopharmaceuticals pharmacology, Reproducibility of Results, Retrospective Studies, Bone Marrow diagnostic imaging, Bone Neoplasms diagnosis, Fluorodeoxyglucose F18 pharmacology, Magnetic Resonance Imaging methods, Multiple Myeloma diagnosis, Positron Emission Tomography Computed Tomography methods
- Abstract
Purpose: To compare the diagnostic performance of MRI and
18 F-FDG-PET/CT in detecting bone marrow involvement (BMI) in patients with multiple myeloma (MM)., Materials and Methods: This retrospective study was approved by our Institutional Review Board. Two radiologists and two nuclear medicine specialists independently and blindly reviewed 84 pairs of MRI and PET/CT scans obtained in 73 MM patients. Readers assessed the presence and patterns of BMI. The best valuable comparator (BVC) for BMI was established by a panel review of all baseline and follow-up imaging, and biological and pathological information. Intra- and inter-reader agreement and correlation between MRI and PET/CT were assessed using the prevalence-adjusted bias-adjusted kappa (k) coefficient. Diagnostic performance of MRI and PET/CT in detecting BMI was evaluated from ROC characteristics. Association between imaging and biological, pathological, and clinical findings was assessed using Wilcoxon rank-sum and chi-square tests., Results: Intra- and inter-reader agreement was very good for MRI (k = 0.90 [0.81; 1.00] and 0.88 [0.78; 0.98]). Intra- and inter-reader agreement was good for PET/CT (k = 0.80 [0.69; 0.91] and 0.71 [0.56; 0.86]). The sensitivity of MRI to detect BMI (97% [90%; 100%]) was significantly superior to that of PET/CT (76% [64%; 85%]) (p < 0.001). The specificity of MRI (86% [57%; 98%]) was lower than that of PET/CT (93% [66%; 100%]), without reaching statistical significance (p = 0.32). There was a strong correlation between decisions regarding patient management and PET/CT findings (p < 0.001)., Conclusion: MRI is significantly more sensitive than PET/CT to detect BMI in MM. Patient management is more strongly correlated with PET/CT findings., Key Points: • MRI and PET/CT have very close diagnostic value for the detection of bone marrow involvement in multiple myeloma. • MRI has a significantly higher sensitivity and better reproducibility. • PET/CT findings appear to have a higher impact on clinical decisions.- Published
- 2020
- Full Text
- View/download PDF
18. Pattern of metastatic deposit in recurrent prostate cancer: a whole-body MRI-based assessment of lesion distribution and effect of primary treatment.
- Author
-
Pasoglou V, Michoux N, Van Damme J, Van Nieuwenhove S, Halut M, Triqueneaux P, Tombal B, and Lecouvet FE
- Subjects
- Aged, Humans, Male, Middle Aged, Neoplasm Metastasis diagnostic imaging, Neoplasm Recurrence, Local therapy, Prostatic Neoplasms therapy, Retrospective Studies, Magnetic Resonance Imaging methods, Neoplasm Recurrence, Local diagnostic imaging, Neoplasm Recurrence, Local pathology, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology, Whole Body Imaging
- Abstract
Purpose: It is generally accepted that when metastases develop in a patient with biochemical recurrence of prostate cancer (PCa), they follow a centrifuge pattern of seeding from the pelvis and that most patients enter the disease as oligometastatic. In this study, we used whole-body magnetic resonance imaging (WB-MRI) to assess the anatomical distribution of oligo- and polymetastatic disease and the impact of the initial treatment on this distribution in patients., Materials and Methods: WB-MRI examinations of patients with a rising prostate-specific antigen (PSA) after radical treatment by surgery or/and radiotherapy were analyzed for disease recurrence. The patients were separated into three groups, based on the primary treatment: patients treated by radical prostatectomy without radiotherapy and with/without lymph node dissection (RP), patients treated only by radiotherapy or hormono-radiotherapy (RT) and patients treated with radical prostatectomy and adjuvant or salvage radiotherapy (RP + RT). Patients with ≤ 5 bone or/and node metastases were considered oligometastatic. Regional distributions of bone and lymph nodes metastases were reported using anatomical diagrams. Univariate and multivariable logistic regressions were performed to identify prognostic factors of relapse., Results: The primary treatment (RP, RT, RP + RT), Gleason score, PSA at relapse, time between first diagnosis and recurrence did not influence the metastatic status (oligo vs. polymetastatic). Oligometastatic patients showed different distribution of bone metastases compared to the polymetastatic ones and the distribution of the oligometastatic disease was not influenced by the primary treatment., Conclusions: In this WB-MRI-based study, there was no evidence that the primary treatment influenced the metastatic status of the patient or the distribution of the oligometastatic disease.
- Published
- 2019
- Full Text
- View/download PDF
19. Perforation from Ingested Wooden Toothpick: A Colon Diverticulitis Mimicker: Key learning point: Foreign bodies should be considered in the differential when imaging displays bowel inflammation.
- Author
-
Dermesropian F, Dewit O, and Pasoglou V
- Abstract
Competing Interests: The authors have no competing interests to declare.
- Published
- 2019
- Full Text
- View/download PDF
20. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
- Author
-
Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, and Lecouvet FE
- Subjects
- Aged, Aged, 80 and over, Bone Neoplasms secondary, Humans, Male, Middle Aged, Neoplasm Metastasis, ROC Curve, Bone Marrow pathology, Bone Neoplasms diagnosis, Diffusion Magnetic Resonance Imaging methods, Multiple Myeloma pathology, Neoplasm Staging methods, Prostatic Neoplasms pathology, Whole Body Imaging methods
- Abstract
Purpose: To compare the diagnostic accuracy of whole-body T1, short tau inversion recovery (STIR), high b-value diffusion-weighted imaging (DWI), and sequence combinations to detect bone involvement in prostate cancer (PCa) and multiple myeloma (MM) patients., Materials and Methods: We included 50 consecutive patients with PCa at high risk for metastasis and 47 consecutive patients with a histologically confirmed diagnosis of MM who received whole-body MRI at two institutions from January to December 2015. Coronal T1, STIR, and reconstructed coronal high b-values DWI were obtained for all patients. Two musculoskeletal radiologists read individual sequences, pairs of sequences (T1-DWI, T1-STIR, and STIR-DWI), and all combined (T1-STIR-DWI) to detect bone involvement. Receiver operating characteristic curve analysis was used to assess diagnostic performance according to a "best valuable comparator" combining baseline and 6-month imaging and clinical and biological data. Interobserver agreement was calculated., Results: Interobserver agreement for individual and combined MRI sequences was very good in the PCa group and ranged from good to very good in the MM group (0.76-1.00). In PCa patients, T1-DWI, T1-STIR, and T1-STIR-DWI showed the highest performance (sensitivity = 100% [95% CI = 90.5-100%], specificity = 100% [75.3-100%]). In MM patients, the highest performance was achieved by T1-STIR-DWI (sensitivity = 100% [88.4-100%], specificity = 94.1% [71.3-100%]). T1-STIR-DWI significantly outperformed all sequences (p < 0.05) except T1-DWI (p = 0.49)., Conclusion: In PCa patients, a combination of either T1-DWI or T1-STIR sequences is not inferior to a combination of three sequences to detect bone metastases. In MM, T1-STIR-DWI and T1-DWI had the highest diagnostic performance for detecting bone involvement., Key Points: • The sequences used in Whole Body MRI studies to detect bone involvement in prostate cancer and myeloma were evaluated. • In prostate cancer, any pairwise combinations of T1, STIR, and DWI have high diagnostic value. • In myeloma, the combinations T1-STIR-DWI or T1-DWI sequences should be used.
- Published
- 2019
- Full Text
- View/download PDF
21. Whole Body MRI and oncology: recent major advances.
- Author
-
Pasoglou V, Michoux N, Larbi A, Van Nieuwenhove S, and Lecouvet F
- Subjects
- Clinical Protocols, Costs and Cost Analysis, Early Detection of Cancer economics, Early Detection of Cancer standards, Humans, Neoplasm Staging, Prognosis, Early Detection of Cancer methods, Early Detection of Cancer trends, Magnetic Resonance Imaging economics, Magnetic Resonance Imaging standards, Whole Body Imaging economics, Whole Body Imaging standards
- Abstract
MRI is a very attractive approach for tumour detection and oncological staging with its absence of ionizing radiation, high soft tissue contrast and spatial resolution. Less than 10 years ago the use of Whole Body MRI (WB-MRI) protocols was uncommon due to many limitations, such as the forbidding acquisition times and limited availability. This decade has marked substantial progress in WB-MRI protocols. This very promising technique is rapidly arising from the research world and is becoming a commonly used examination for tumour detection due to recent technological developments and validation of WB-MRI by multiple studies and consensus papers. As a result, WB-MRI is progressively proposed by radiologists as an efficient examination for an expanding range of indications. As the spectrum of its uses becomes wider, radiologists will soon be confronted with the challenges of this technique and be urged to be trained in order to accurately read and report these examinations. The aim of this review is to summarize the validated indications of WB-MRI and present an overview of its most recent advances. This paper will briefly discuss how this examination is performed and which are the recommended sequences along with the future perspectives in the field.
- Published
- 2018
- Full Text
- View/download PDF
22. Acute Abdomen with Periumbilical Erythema.
- Author
-
Alice P and Pasoglou V
- Abstract
A 33-year-old man with a history of a Malone Antegrade Continence Enema Procedure presented to the Emergency Department with right lower abdominal pain. Computed Tomography (CT) of the abdomen revealed an appendicitis of the appendicostomy with an associated appendicolith.
- Published
- 2018
- Full Text
- View/download PDF
23. Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI.
- Author
-
Pasoglou V, Michoux N, Tombal B, and Lecouvet F
- Abstract
Multiparametric Magnetic Resonance Imaging (mp-MRI) is the current standard of reference for the local staging of prostate cancer (PCa). On the other hand, despite the low sensitivity and specificity of Technetium Bone Scanning (BS) for the detection of bone metastases (BM) and of Body Computed Tomography CT for the detection of lymph node metastases (LNM), these techniques are routinely used, in the current clinical practice. Nevertheless, whole Body MRI (WB-MRI) and Positron Emission Tomography Computed Tomography (PET-CT) are emerging as robust tools for the staging of oncologic patients, including those with (PCa). The available techniques (BS, WB-MRI, PET, CT) for the detection of BM in oncologic patients were compared and showed striking center differences in terms of anatomic sequences and planes used. This heterogeneity and the long acquisition time of WB-MRI protocols - due to the addition of multiple anatomic sequences in different planes - questioned whether a single three dimensional (3D) sequence could replace the multiple anatomic sequences used for node and bone staging of PCa. We demonstrated that WB-MRI is a credible tool for the detection of bone and node metastasis. The second question addressed the possibility to obtain a complete TNM staging of PCa in a single MRI session. A WB-MRI protocol was developed to enable complete, T (local), N (regional) and M (distant) staging of PCa in a single session, in less than an hour. This 'all-in-one' protocol proved to be as efficient as the sum of exams currently in use for the staging of PCa (ie: mp-MRI of the prostate for 'T' staging, Thoraco-abdominal CT for 'N' staging and bone scintigraphy for 'M' staging).
- Published
- 2016
- Full Text
- View/download PDF
24. Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease.
- Author
-
Larbi A, Dallaudière B, Pasoglou V, Padhani A, Michoux N, Vande Berg BC, Tombal B, and Lecouvet FE
- Subjects
- Aged, Bone Neoplasms diagnostic imaging, Bone Neoplasms secondary, Humans, Lymph Node Excision, Lymph Nodes pathology, Lymphatic Metastasis diagnostic imaging, Male, Middle Aged, Prostatectomy, Viscera diagnostic imaging, Magnetic Resonance Imaging, Neoplasm Metastasis diagnostic imaging, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms therapy, Radiotherapy, Whole Body Imaging
- Abstract
Objectives: To determine the proportion of prostate cancer (PCa) patients with oligometastatic disease (≤3 synchronous lesions) using whole body magnetic resonance imaging with diffusion-weighted imaging (WB-MRI/DWI). To determine the proportion of patients with nodal disease confined within currently accepted target areas for extended lymph node dissection (eLND) and pelvic external beam radiation therapy (EBRT)., Subjects and Methods: Two radiologists reviewed WB-MRI/DWI studies in 96 consecutive newly diagnosed metastatic PCa patients; 46 patients with newly diagnosed castration naive PCa (mHNPC) and 50 patients with first appearance of metastasis during monitoring for non-metastatic castration resistant PCa (M0 to mCRPC). The distribution of metastatic deposits was assessed and the proportions of patients with oligometastatic disease and with LN metastases located within eLND and EBRT targets were determined., Results: Twenty-eight percent of mHNPC and 50% of mCPRC entered the metastatic disease with ≤3 sites. Bone metastases (BM) were identified in 68.8% patients; 71.7% of mHNPC and 66% mCRPC patients. Most commonly involved areas were iliac bones and lumbar spine. Enlarged lymph nodes (LN) were detected in 68.7% of patients; 69.6% of mHNPC and 68.0% of mCRPC. Most commonly involved areas were para-aortic, inter-aortico-cava, and external iliac areas. BM and LN were detected concomitantly in 41% of mHNPC and 34% of mCRPC. Visceral metastases were detected in 6.7%. Metastatic disease was confined to LN located within the accepted boundaries of eLND or pelvic EBRT target areas in only ≤25% and ≤30% of patients, respectively., Conclusions: Non-invasive mapping of metastatic landing sites in PCa using WB-MRI/DWI shows that 28% of the mHNPC patients, and 52% of the mCRPC can be classified as oligometastatic, thus challenging the concept of metastatic targeted therapy. More than two thirds of metastatic patients have LN located outside the usually recommended targets of eLND and pelvic EBRT. Prophylactic or salvage treatments of these sole areas in patients with high-risk prostate cancer may not prevent the emergence of subsequent metastases. Prostate 76:1024-1033, 2016. © 2016 Wiley Periodicals, Inc., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
25. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
- Author
-
Pasoglou V, Michoux N, Peeters F, Larbi A, Tombal B, Selleslagh T, Omoumi P, Vande Berg BC, and Lecouvet FE
- Subjects
- Aged, Androgen Antagonists therapeutic use, Biomarkers, Tumor blood, Humans, Image Interpretation, Computer-Assisted, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Prostate-Specific Antigen blood, Prostatic Neoplasms drug therapy, Sensitivity and Specificity, Bone Neoplasms secondary, Imaging, Three-Dimensional, Lymphatic Metastasis diagnosis, Magnetic Resonance Imaging methods, Prostatic Neoplasms pathology, Whole Body Imaging
- Abstract
Purpose: To develop and assess the diagnostic performance of a three-dimensional (3D) whole-body T1-weighted magnetic resonance (MR) imaging pulse sequence at 3.0 T for bone and node staging in patients with prostate cancer. MATERIALS AND METHODS This prospective study was approved by the institutional ethics committee; informed consent was obtained from all patients. Thirty patients with prostate cancer at high risk for metastases underwent whole-body 3D T1-weighted imaging in addition to the routine MR imaging protocol for node and/or bone metastasis screening, which included coronal two-dimensional (2D) whole-body T1-weighted MR imaging, sagittal proton-density fat-saturated (PDFS) imaging of the spine, and whole-body diffusion-weighted MR imaging. Two observers read the 2D and 3D images separately in a blinded manner for bone and node screening. Images were read in random order. The consensus review of MR images and the findings at prospective clinical and MR imaging follow-up at 6 months were used as the standard of reference. The interobserver agreement and diagnostic performance of each sequence were assessed on per-patient and per-lesion bases., Results: The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were significantly higher with whole-body 3D T1-weighted imaging than with whole-body 2D T1-weighted imaging regardless of the reference region (bone or fat) and lesion location (bone or node) (P < .003 for all). For node metastasis, diagnostic performance (area under the receiver operating characteristic curve) was higher for whole-body 3D T1-weighted imaging (per-patient analysis; observer 1: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P = .006 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging; observer 2: P = .006 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P = .006 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging), as was sensitivity (per-lesion analysis; observer 1: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P < .001 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging; observer 2: P < .001 for 2D T1-weighted imaging vs 3D T1-weighted imaging, P < .001 for 2D T1-weighted imaging + PDFS imaging vs 3D T1-weighted imaging)., Conclusion: Whole-body MR imaging is feasible with a 3D T1-weighted sequence and provides better SNR and CNR compared with 2D sequences, with a diagnostic performance that is as good or better for the detection of bone metastases and better for the detection of lymph node metastases., (© RSNA, 2014 Online supplemental material is available for this article.)
- Published
- 2015
- Full Text
- View/download PDF
26. Familial adhesive arachnoiditis associated with syringomyelia.
- Author
-
Pasoglou V, Janin N, Tebache M, Tegos TJ, Born JD, and Collignon L
- Subjects
- Adolescent, Adult, Belgium, Child, Female, Humans, Male, Middle Aged, Tissue Adhesions congenital, Tissue Adhesions pathology, Arachnoiditis congenital, Arachnoiditis pathology, Magnetic Resonance Imaging, Syringomyelia congenital, Syringomyelia pathology
- Abstract
Adhesive arachnoiditis is a rare condition, often complicated by syringomyelia. This pathologic entity is usually associated with prior spinal surgery, spinal inflammation or infection, and hemorrhage. The usual symptoms of arachnoiditis are pain, paresthesia, and weakness of the low extremities due to the nerve entrapment. A few cases have had no obvious etiology. Previous studies have reported one family with multiple cases of adhesive arachnoiditis. We report a second family of Belgian origin with multiple cases of arachnoiditis and secondary syringomyelia in the affected individuals., (© 2014 by American Journal of Neuroradiology.)
- Published
- 2014
- Full Text
- View/download PDF
27. One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?
- Author
-
Pasoglou V, Larbi A, Collette L, Annet L, Jamar F, Machiels JP, Michoux N, Vande Berg BC, Tombal B, and Lecouvet FE
- Subjects
- Aged, Aged, 80 and over, Humans, Lymph Nodes pathology, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Magnetic Resonance Imaging methods, Prostatic Neoplasms pathology, Whole Body Imaging methods
- Abstract
Background: Multiparametric magnetic resonance imaging (mpMRI) is the standard for local prostate cancer (PCa) staging. Whole-body MRI (wbMRI) has shown capabilities for metastatic screening. This study assesses the feasibility and value of an all-in-one AJCC TNM staging of PCa during a unique MRI session combining mpMRI and wbMRI., Methods: Thirty consecutive patients with "high-risk" PCa prospectively underwent mpMRI of the prostate and wbMRI, in addition to (99m) Tc bone scan (BS), completed with standard X-rays (±TXR) and contrast enhanced CT for distant staging. For the statistical analysis, a "best valuable comparator" (BVC) combining a panel review of all available baseline and follow-up imaging, biological, and clinical data was used to adjudicate lymph node and bone metastatic status., Results: Prostate mpMRI was analyzed using ESUR guidelines. Sensitivity of BS ± TXR combined with CT and of wbMRI for detecting metastases (bones or nodes) was 85% and 100%, respectively, and specificity was 88% and 100%, respectively. For the overall staging of the patients as being either N0M0 or having disease extension beyond the prostate, wbMRI was superior to the combination of BS and CT (improvement in all ROC characteristics and of AUC by 13.6% (95% CI: +0.7% to +26.5%, P = 0.039)). The main limitation is the limited number of patients., Conclusions: AJCC M and N staging using wbMRI is feasible during the same imaging session as mpMRI performed for T staging, in less then one hour. wbMRI outperforms BS ± TXR and abdomino-pelvic CT work up for discriminating subsets of patients with or without distant spread of the cancer., (© 2013 Wiley Periodicals, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
28. Novel imaging techniques reshape the landscape in high-risk prostate cancers.
- Author
-
Lecouvet FE, Lhommel R, Pasoglou V, Larbi A, Jamar F, and Tombal B
- Subjects
- Bone Neoplasms blood, Bone Neoplasms diagnostic imaging, Bone Neoplasms secondary, Humans, Kallikreins blood, Lymphatic Metastasis, Magnetic Resonance Imaging, Male, Multimodal Imaging, Neoplasm Grading, Positron-Emission Tomography, Predictive Value of Tests, Prognosis, Prostate-Specific Antigen blood, Prostatic Neoplasms blood, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology, Radiopharmaceuticals, Risk Factors, Tomography, X-Ray Computed, Bone Neoplasms diagnosis, Diagnostic Imaging methods, Prostatic Neoplasms diagnosis
- Abstract
Purpose of Review: High-risk prostate cancers (PCa), that is, those with prostate-specific antigen greater than 20 ng/dl, Gleason Score of at least 8, or extraprostatic spread, are nowadays commonly treated by surgery and radiotherapy combined with a fixed period of systemic treatment. Implementing these strategies requires an exhaustive assessment of metastatic spread. This review addresses the latest development in integrated imaging techniques., Recent Findings: In contrast to the progress that has been made in PCa treatment, diagnostic strategies have not much evolved. Most guidelines still recognize (99m)Tc bone scintigraphy and computed tomography (CT) as cornerstone modalities to assess metastatic spread in bones and lymph nodes. Therefore, modern imaging techniques should primarily focus on these two targets. PET with various tracers, including (11)C or (18)F-choline and (18)F-sodium fluoride, and MRI with or without diffusion-weighted imaging are competing to supplant bone scan and CT scan as reference imaging techniques. This review focuses on the latest development of these techniques and analyses their potential impact in everyday urology practice., Summary: Although certain hurdles remain, PET and whole-body MRI have the ability to supplant (99m)Tc bone scan and CT as upfront test to assess metastatic spread in high-risk PCa.
- Published
- 2013
- Full Text
- View/download PDF
29. Sternal cleft: prenatal multimodality imaging.
- Author
-
Pasoglou V, Tebache M, Rausin L, Demarche M, and Collignon L
- Subjects
- Diagnosis, Differential, Female, Heart Defects, Congenital surgery, Humans, Infant, Newborn, Magnetic Resonance Imaging, Musculoskeletal Abnormalities surgery, Pregnancy, Sternum abnormalities, Sternum surgery, Tomography, X-Ray Computed, Ultrasonography, Prenatal, Heart Defects, Congenital diagnosis, Musculoskeletal Abnormalities diagnosis
- Abstract
Sternal clefts have been reported sporadically, but there are no reports describing complete investigations of the malformation. We describe a child with isolated inferior sternal cleft diagnosed at 33 weeks of gestation and thoroughly investigated by prenatal US, MRI and CT and preoperative US. Our report highlights the importance of accurate and in-depth investigation by multimodality imaging that allows detection of accompanying serious anomalies and, hence, forms the basis for informed parental counselling and for postnatal interdisciplinary care.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.